Verity Asset Management, Inc. Abbott Laboratories Transaction History

Verity Asset Management, Inc.

$177 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $36,883 - $43,269	-388 Reduced 6.73%	5,374 $590 Million
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $84,761 - $98,138	-876 Reduced 13.2%	5,762 $558 Million
Q1 2022 May 23, 2022	SELL	$114.02 - $139.04 $2.28 Million - $2.78 Million	-20,006 Reduced 75.09%	6,638 $786,000
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $2.31 Million - $2.81 Million	20,235 Added 315.73%	26,644 $786,000
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $10,744 - $13,155	93 Added 1.47%	6,409 $902,000
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $66,962 - $74,080	-574 Reduced 8.33%	6,316 $746,000
Q2 2021 Aug 04, 2021	BUY	$105.79 - $124.53 $30,044 - $35,366	284 Added 4.3%	6,890 $799,000
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $60,079 - $70,782	552 Added 9.12%	6,606 $792,000
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $63,210 - $68,880	602 Added 11.04%	6,054 $663,000
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $65,705 - $79,794	-717 Reduced 11.62%	5,452 $593,000
Q2 2020 Nov 13, 2020	BUY	$76.57 - $98.0 $52,680 - $67,424	688 Added 12.55%	6,169 $564,000
Q1 2020 May 18, 2020	BUY	$62.82 - $91.86 $16,207 - $23,699	258 Added 4.94%	5,481 $433,000
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $23,553 - $26,220	-300 Reduced 5.43%	5,223 $454,000
Q3 2019 Nov 01, 2019	SELL	$81.84 - $88.74 $74,801 - $81,108	-914 Reduced 14.2%	5,523 $462,000
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $24,123 - $28,135	331 Added 5.42%	6,437 $541,000
Q2 2019 Aug 06, 2019	BUY	$72.88 - $85.0 $18,584 - $21,675	255 Added 4.36%	6,106 $372,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $19,534 - $23,617	295 Added 5.31%	5,851 $468,000
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $65,887 - $74,641	-1,005 Reduced 15.32%	5,556 $402,000
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $27,668 - $33,378	455 Added 7.45%	6,561 $481,000
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $19,516 - $21,540	339 Added 5.88%	6,106 $372,000
Q1 2018 May 02, 2018	BUY	$56.27 - $63.62 $17,162 - $19,404	305 Added 5.58%	5,767 $346,000
Q4 2017 Feb 07, 2018	BUY	$53.68 - $57.47 $293,200 - $313,901	5,462	5,462 $340,000

Others Institutions Holding ABT

# of Institutions

3,361

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

Vanguard Group Inc Valley Forge, PA

169M
Shares

$22.8 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$17.7 Billion
0.31% of portfolio
State Street Corp Boston, MA

77.2M
Shares

$10.4 Billion
0.35% of portfolio
Capital International Investors Los Angeles, CA

68M
Shares

$9.17 Billion
1.51% of portfolio
Capital Research Global Investors Los Angeles, CA

54.1M
Shares

$7.3 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Verity Asset Management, Inc. with notifications on news.

Account